Stephen Murchan, Ireland
Health Protection and Surveillance Centre EpidemiologyAuthor Of 4 Presentations
RESOLVING THE PERSISTENCE OF SEROTYPE 19A IN IRELAND AFTER PCV13 INTRODUCTION, RESULTS FROM 2007-2018 (ID 219)
Session Name
Clinical Sciences - Disease Burden in Infants, Children/Youth, and Adults
Presenter
THE POTENTIAL PROTECTION OFFERED BY BROADER PCV VACCINES IN OLDER ADULTS – IRISH IPD SURVEILLANCE FROM 2007-08 TO 2018-19 (ID 810)
Session Name
Vaccines - Impact of Vaccine programs and Serotype Replacement
Presenter
THE THREAT POSED BY INCREASED NON-PCV13 SEROTYPES IN CHILDREN – RESULTS FROM IRISH SURVEILLANCE DATA FROM 2007-08 TO 20017-18 (ID 886)
Session Name
Clinical Sciences - Disease Burden in Infants, Children/Youth, and Adults
Presenter
GENETIC VARIATION ASSOCIATED WITH SEROTYPE 19A VACCINE FAILURES IN IRELAND (ID 1139)
Session Name
Basic Sciences - Genomics and Transmission
Presenter